Non-Infectious Pneumonitis and Acute Respiratory Distress Syndrome in a Patient on Ustekinumab Treatment: Case Report and Literature Review

Non-Infectious Pneumonitis and Acute Respiratory Distress Syndrome in a Patient on Ustekinumab Treatment: Case Report and Literature Review

Ustekinumab is a monoclonal antibody targeting the p40 subunit of IL-12 and IL-23, approved for treating psoriasis, psoriatic arthritis, and inflammatory bowel disease. Despite a remarkable success in treating chronic inflammatory conditions and a generally favorable safety profile, its role in indu...

Full description

Bibliographic Details
Main Authors: Valentina Cioffi, Giulia Di Napoli, Pierfrancesco Tozzi, Sabina Martelli, Katia Bruno, Andrea Longo, Helena Buso, Francesco Pugliese, Cinzia Milito
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Life
Subjects:
Ustekinumab
non-infectious pneumonitis
ARDS
ECMO
long-term treatment
Online Access:https://www.mdpi.com/2075-1729/14/3/394

Internet

https://www.mdpi.com/2075-1729/14/3/394

Similar Items